Atlas Capital Advisors Inc. recently made a new investment in Ford Motor Company, acquiring 99,390 shares valued at approximately $1.3 million in the fourth quarter. Institutional investors and hedge funds collectively hold 58.74% of Ford's stock, with several firms increasing their stakes. The article discusses mixed sentiment around Ford, highlighting a Goldman Sachs price target increase alongside recent vehicle recalls.

Atlas Capital Advisors Inc. initiated a new position in Gilead Sciences, Inc. (NASDAQ:GILD) during the fourth quarter, acquiring 8,234 shares valued at approximately $1.01 million. The biopharmaceutical company recently reported strong Q1 results, beating EPS and revenue estimates, and announced a quarterly dividend of $0.82 per share. Analysts maintain a "Moderate Buy" rating with an average price target of $156.93, driven by positive Phase 3 HIV trial results and oncology pipeline progress.

Arrowstreet Capital Limited Partnership significantly increased its stake in Gen Digital Inc. ($GEN) by 36% in the fourth quarter, now holding 8.98 million shares valued at $244.13 million. This comes as Gen Digital reported strong quarterly earnings of $0.67 per share, surpassing estimates, and a 27% year-over-year revenue increase to $1.28 billion. Despite this, analysts maintain a cautious "Hold" rating on the stock with an average price target of $31.29.

Arax Advisory Partners reduced its stake in Medtronic PLC by 44.6% in the fourth quarter, holding 27,363 shares valued at approximately $2.63 million. This move comes as Medtronic reported strong quarterly results, beating expectations with an EPS of $1.55 and revenue of $9.81 billion, a 9.9% increase year-over-year. The company also announced a quarterly dividend increase to $0.72 per share, yielding about 3.6%.

The Schall Law Firm has announced a class action lawsuit against Calix, Inc. (NYSE: CALX) for alleged securities fraud, encouraging investors who purchased shares between January 28, 2026, and April 21, 2026, to contact the firm. The lawsuit claims Calix made false and misleading statements regarding its Q1 margins, which were inflated by advanced purchasing of memory components, leading to negative margin pressure as supply decreased and prices rose. Investors who suffered losses are urged to join the case before the July 27, 2026, deadline.

The Schall Law Firm has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged securities fraud. Investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, are encouraged to contact the firm to join the lawsuit before July 13, 2026. The lawsuit claims that Phreesia made false and misleading statements regarding its long-term growth outlook and fiscal year 2027 projections, particularly concerning its pharmaceutical marketing commitments.

Teradyne Robotics, encompassing Universal Robots and Mobile Industrial Robots, will demonstrate its production-ready physical AI applications at Automate 2026. The company will showcase how its solutions, including the MiR1200 Pallet Jack and the new PolyScope X software platform, are transforming industrial automation by enabling robots to perform tasks in dynamic, unstructured environments. Demos will highlight applications in data centers, AI training, and various manufacturing processes, emphasizing the practical deployment of AI in robotics.

The Invesco Rochester AMT-Free New York Municipal Fund Class A shares at net asset value outperformed its style-specific index in Q1 2026 due to strategic duration exposure and key sector allocations like revenue bonds. Despite a slowdown, credit rating upgrades still exceeded downgrades, indicating strong underlying fundamentals in state and local government budgets. Management maintains an opportunistic duration exposure, focusing on longer-dated securities.

Arrowstreet Capital Limited Partnership increased its stake in Motorola Solutions by 15.9% in the fourth quarter, acquiring an additional 96,751 shares and bringing its total holding to 706,588 shares valued at approximately $270.8 million. This comes as Motorola Solutions reported strong quarterly results, beating EPS and revenue estimates, and provided positive guidance for Q2 and the full year 2026. The company also declared a quarterly dividend of $1.21 per share, while analysts maintain a generally positive outlook with an average "Buy" rating.

Arrowstreet Capital Limited Partnership significantly reduced its stake in Procter & Gamble (PG) by 61.3% in the fourth quarter, selling nearly 2 million shares but still retaining 1.24 million shares valued at $178.05 million. Despite this, Procter & Gamble reported strong quarterly earnings, beating EPS expectations, and increased its quarterly dividend. Analysts maintain a "Moderate Buy" rating for PG with a consensus price target of $160.78.